Connection
Jeffrey Kern to STAT3 Transcription Factor
This is a "connection" page, showing publications Jeffrey Kern has written about STAT3 Transcription Factor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.476 |
|
|
|
-
Dowlati A, Kluge A, Nethery D, Halmos B, Kern JA. SCH66336, inhibitor of protein farnesylation, blocks signal transducer and activators of transcription 3 signaling in lung cancer and interacts with a small molecule inhibitor of epidermal growth factor receptor/human epidermal growth factor receptor 2. Anticancer Drugs. 2008 Jan; 19(1):9-16.
Score: 0.253
-
Kluge A, Dabir S, Kern J, Nethery D, Halmos B, Ma P, Dowlati A. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer. Int J Cancer. 2009 Oct 01; 125(7):1728-34.
Score: 0.072
-
Cortas T, Eisenberg R, Fu P, Kern J, Patrick L, Dowlati A. Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer. Lung Cancer. 2007 Mar; 55(3):349-55.
Score: 0.059
-
Dowlati A, Nethery D, Kern JA. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy. Mol Cancer Ther. 2004 Apr; 3(4):459-63.
Score: 0.049
-
Liu J, Kern JA. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. Am J Respir Cell Mol Biol. 2002 Sep; 27(3):306-13.
Score: 0.044